Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial-Reference-Cited by-同舟云学术

Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial

Published:2024-01 Issue: Volume: Page:102383
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Lobo Suzana Margareth,Plantefève Gaétan,Nair Girish,Joaquim Cavalcante Adilson,Franzin de Moraes Nara,Nunes Estevao,Barnum Otis,Berdun Stadnik Claudio Marcel,Lima Maria Patelli^ORCID,Lins Muriel,Hajjar Ludhmila Abrahao,Lipinski Christopher,Islam Shaheen,Ramos Fabiano,Simon Tiago,Martinot Jean-Benoît,Guimard Thomas,Desclaux Arnaud,Lioger Bertrand,Neuenschwander Fernando Carvalho,DeSouza Paolino Bruno,Amin Alpesh,Acosta Samuel Amil,Dilling Daniel Forde,Cartagena Edgardo,Snyder Brian,Devaud Edouard,Barreto Berselli Marinho Ana Karolina^ORCID,Tanni Suzana,Milhomem Beato Patricia Medeiros,De Wit Stephan,Selvan Vani,Gray Jeffrey,Fernandez Ricardo,Pourcher Valérie,Maddox Lee,Kay Richard,Azbekyan Anait,Chabane Mounia,Tourette Cendrine,Esmeraldino Luis Everton,Dilda Pierre J.,Lafont René,Mariani Jean,Camelo Serge^ORCID,Rabut Sandrine,Agus Samuel^ORCID,Veillet Stanislas,Dioh Waly,van Maanen Rob,Morelot-Panzini Capucine

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Vaccinations against COVID-19 may have averted up to 140,000 deaths in the United States;Gupta;Health Aff (Millwood),2021

2. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US;Gupta;JAMA Intern Med,2020

3. COVID-19 mortality and progress toward vaccinating older adults - world health organization, worldwide, 2020-2022;Wong;MMWR Morb Mortal Wkly Rep,2023

4. Effect of high-flow oxygen therapy vs conventional oxygen therapy on invasive mechanical ventilation and clinical recovery in patients with severe COVID-19: a randomized clinical trial;Ospina-Tascon;JAMA,2021

5. Dexamethasone in hospitalized patients with Covid-19 - preliminary report;Horby;N Engl J Med,2020